There are exciting opportunities ahead in biotech, especially in gene editing, stem cells, immunotherapy, and neuroscience.
Biotech is high risk high reward. The smart way to play biotech is to buy several stocks and keep the quantities small.
There is a good time to buy innovation, and a poor time to buy innovation. In current market conditions and sentiment, investors have been selling long duration, speculative stocks on good news, further dropping the price. Prudent investors will be patient. It is wise to trade the market you are in, not the one you want to be in.
The podcast highlights individual stocks and ETFs that will likely do well in the current market environment.
Symbols: ABBV, ALEC, AMLX, BEAM, BMY, BSX, CRSP, CVS, CYP, EDIT, EXAS, FATE, HRMY, ITCI, JNJ, JUNO, KITE, LLY, MRK, NTLA, NVTA, ONVO, PFE, REGN, RVNC, THMO, TMO, UNH, UTHR, VRTX, XBI, XLV